Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Restrictive cardiomyopathy and Tricuspid regurgitation; and common findings: Hepatic artery hyperplasia, Ascites, Enlarged liver (hepatomegaly), and Hydrops fetalis and others.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Digestive system | 3 | Hepatic artery hyperplasia, Ascites, Enlarged liver (hepatomegaly) |
KIF20A encodes kinesin family member 20A (890 aa). Mitotic kinesin required for chromosome passenger complex (CPC)-mediated cytokinesis. Following phosphorylation by PLK1, involved in recruitment of PLK1 to the central spindle. Highest expression in Cells EBV-transformed lymphocytes (39.5 TPM) and Cells Cultured fibroblasts (30.8 TPM).
Cardiomyopathy, familial restrictive, 6 is associated with mutations in the KIF20A gene on chromosome 5.
KIF20A is classified as a druggable target with score 0.0.
Genetic testing for KIF20A is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for cardiomyopathy, familial restrictive, 6 has been reported in the published literature.
Phenotype severity distribution: 2 always present features, 7 common features.
No clinical trials have been registered for cardiomyopathy, familial restrictive, 6.
32 publications have been identified in PubMed for cardiomyopathy, familial restrictive, 6. Research spans Diagnostic / Biomarker (22%), Basic Science / Preclinical (22%), and Epidemiology / Natural History (22%).
Research Type | Count | % of Total |
|---|---|---|
Testing and diagnosis research | 7 | 22% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 9:41 PM UTC
Online Mendelian Inheritance in Man
Common questions about cardiomyopathy, familial restrictive, 6
Heart and blood vessels |
1 |
Restrictive cardiomyopathy |
Pregnancy and birth | 1 | Hydrops fetalis |
Age of onset: before birth.
Laboratory research
7 |
22% |
Disease patterns and progression | 7 | 22% |
Patient case studies | 5 | 16% |
Research summaries | 3 | 9% |
Clinical study results | 2 | 6% |
New treatment approaches | 1 | 3% |
Berillo O (2026). [PMID: 42253124](https://pubmed.ncbi.nlm.nih.gov/42253124/). *J Hypertens*. [Basic Science / Preclinical]
Arslan A (2026). [PMID: 42165793](https://pubmed.ncbi.nlm.nih.gov/42165793/). *Neuro Endocrinol Lett*. [Epidemiology / Natural History]
Wagner MJ (2026). [PMID: 39774709](https://pubmed.ncbi.nlm.nih.gov/39774709/). *Pediatr Cardiol*. [Epidemiology / Natural History]
Lu R (2026). [PMID: 41569308](https://pubmed.ncbi.nlm.nih.gov/41569308/). *Circ Heart Fail*. [Diagnostic / Biomarker]
de Villiers C (2026). [PMID: 41672210](https://pubmed.ncbi.nlm.nih.gov/41672210/). *Heart Rhythm*. [Basic Science / Preclinical]
Caro-Dominguez P (2026). [PMID: 41193817](https://pubmed.ncbi.nlm.nih.gov/41193817/). *Pediatr Radiol*. [Review / Meta-Analysis]
Debonnaire P (2026). [PMID: 41342126](https://pubmed.ncbi.nlm.nih.gov/41342126/). *Circ Cardiovasc Imaging*. [Diagnostic / Biomarker]
Zampieri M (2026). [PMID: 41732853](https://pubmed.ncbi.nlm.nih.gov/41732853/). *Circ Heart Fail*. [Diagnostic / Biomarker]
Willixhofer R (2025). [PMID: 39543932](https://pubmed.ncbi.nlm.nih.gov/39543932/). *ESC Heart Fail*. [Epidemiology / Natural History]
Asatryan B (2025). [PMID: 39968648](https://pubmed.ncbi.nlm.nih.gov/39968648/). *Circ Genom Precis Med*. [Review / Meta-Analysis]